Sunday, November 8, 2026

GBP/EUR Bearish Momentum: 0.92% Down In The Last 10 Sessions

ViaNews Editorial Team

December 19, 2023

GBP/EUR Bearish Momentum: 0.92% Down In The Last 10 Sessions

(VIANEWS) - GBP/EUR (GBPEUR) has been up by 0.92% for the last 10 sessions. At 21:08 EST on Monday, 18 December, GBP/EUR (GBPEUR) is $1.16.

GBP/EUR's yearly highs and lows, it's 3.879% up from its 52-week low and 1.725% down from its 52-week high.

Volatility

GBP/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.10%, a positive 0.08%, and a positive 0.19%, respectively.

GBP/EUR's highest amplitude of average volatility was 0.18% (last week), 0.19% (last month), and 0.19% (last quarter), respectively.

News about

  • According to FXStreet on Monday, 18 December, "Furthermore, the USD/JPY pair's inability to move back above the said support-turned-resistance, currently around the 142.55 region, validates the negative outlook. ", "This, in turn, warrants some caution before confirming that the USD/JPY pair has formed a near-term bottom around the 141.00 mark and positioning for any further appreciating move. "
  • Usd/jpy forecast: looks threatened - 18 December 2023. According to DailyForex on Monday, 18 December, "At the end of the day, the fate of the USD/JPY exchange rate remains uncertain as it hovers around the ¥142 level. ", "In the absence of clear guidance from the BOJ, the USD/JPY exchange rate is likely to continue its back-and-forth pattern as traders attempt to establish a solid base. "
  • Boj preview: any hawkish surprise in communication to push usd/jpy close to the 140 support – ING. According to FXStreet on Monday, 18 December, "Expect any hawkish surprise in communication to push USD/JPY close to the 140 support, whereas an unchanged message can bring the pair back to 145, where we could see selling interest if the Dollar momentum proves soft."

More news about GBP/EUR (GBPEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com